MKI67 and neoplasm: These included a higher frequency of SBR grade III tumors, elevated levels of ki67 (≥30%), larger tumor size (>3 cm), absence of in situ component, negative ER/PR (estrogen and progesterone) receptor status, and positive Her2 receptor overexpression.